Nanoform Finland Plc – Manager’s transactions – Mads Laustsen
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Nanoform Finland Plc – Manager’s transactions – Jeanne Thoma
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Nanoform Finland Plc – Manager’s transactions – Miguel Calado
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Apalutamide Study Again Demonstrates the Advantages of Nanoforming Over Traditional Cancer Treatment Formulations
Press Release Nanoform Finland Plc February 29, 2024 08:11 a.m.…
Strong momentum in Project Nanoenzalutamide
Company Announcement Nanoform Finland Plc February 29, 2024 08:10 a.m.…
Annual Review 2023. Financial Statements for financial year 2023
To the report To the webcast
Invitation to Nanoform’s Q4 and FY 2023 Report Presentation
Press release Nanoform Finland Plc February 16, 2024 11:00 a.m.…
Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines
Inside information Nanoform Finland Plc February 15, 2024 12:45 Finnish…